Global COVID-19 Monument Design Competition Winner Announced
CHICAGO, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The COVID-19 Monument Commission announces the winner of their global design contest for the COVID-19 Monument of Honor, Remembrance, and Resilience, scheduled to unveil spring 2025 in Chicago, Illinois. Casey Schachner, Assistant Professor of Art in the Betty Foy Sanders Department of Art at Georgia Southern University, has won the $20,000 prize. Her sculpture concept features the dandelion flower as a metaphor for the worldwide pandemic experience. Visually, she references the starburst dandelion’s aesthetic affinity to the official CDC renderings of the COVID-19 virus. Metaphysically, her vision embodies beauty through ashes, rebirth, hope, and resilience---seminal emotions which the Commission set out to promulgate.
Professor Schachner earned her BFA in Sculpture from Baylor University and her MFA in Studio Art from the University of Montana. She exhibits her work nationally and internationally, ranging from temporary site-specific installations to permanent public artworks. In 2011, she served as an Artist in Residence at the University of Georgia Lamar Dodd School of Art in Cortona, Italy and in 2012 as an Artist in Residence at the Carving Studio & Sculpture Center in Vermont. She was the 2017 Emerging Artist for Blackfoot Pathways, an International Sculpture Park in Lincoln, Montana. In 2018, she received a People's Choice award at the Public Art Exhibition on Hilton Head Island in South Carolina. In 2022, Schachner was one of three recipients of the Georgia Sea Grant for Artists, Writers, and Scholars program. She currently lives in Savannah, Georgia with her husband and 3-year-old daughter, who was born during the first year of the pandemic. Schachner shared the surreal experience of receiving her first ultrasound during her pregnancy in the backseat of her car. These events contributed to her visceral and personal reactions navigating the pandemic in the early lockdown days and resonated in her desire to create a design for the Hektoen COVID-19 Monument competition.
The competition ran from April to September of this year and was open to everyone throughout the world over the age of 18. A robust social media campaign encouraged the global citizenry to participate, as according to Commission Chair Dr. Sally Metzler, “The pandemic affected us all; it was 100% inclusive. Every citizen, nation, race, & religion experienced the pandemic. Whether at best, lockdown, or at worst, loss of life or loss of a loved-one, COVID-19 left no one unscathed.”
The Illinois Medical District (IMD) (https://medicaldistrict.org/) a special-use urban zoning area of 560 acres in Chicago, has generously donated the land for the monument, which will incorporate a park that will harmonize with the nature theme of the dandelion monument. The site will welcome all to reflect on the pandemic as a collective and individual experience. Incorporated into the park will be tributes to frontline workers of all facets and to those who lost their lives in the pandemic’s scourge.
Embracing over two hundred variegated species, dandelions grow throughout the world, thus the familiarity of the flower, concomitant with the folklore of blowing on a dandelion to fulfill a wish, engender the appeal of Schachner’s design. The omnipresence of the dandelion embodies universality and inclusion. Ms. Allyson Hanson, the CEO and Executive Director of the IMD, cited her enthusiasm for Schachner’s design visually and for the revered medicinal qualities of the dandelion, as the IMD hosts four premiere hospitals in addition to over 40 healthcare and scientific research facilities.
Metzler emphasized the dual nature of the COVID-19 Monument, that of a physical and potent virtual presence. Funding for the monument is a grass-roots effort, and the volunteer-led Commission encourages everyone throughout the world to donate what they can, even $10 will make a difference, directly through the website: (https://covidmemorialmonument.org/). Corporate sponsorships will provide worldwide recognition at the monument site and on the website, which will offer in perpetuity a virtual platform for the global pandemic experience.
For those who perished, for those who lost a loved-one, for those who have recovered, and for those who courageously and selflessly served during the darkest and most uncertain days of the pandemic, the COVID-19 Monument will mark an event in history that must not be forgotten. Please visit the website to read more and donate today! (https://covidmemorialmonument.org.)
Interested parties are encouraged to follow the monument on social media:
For more information:
Dr. Sally Metzler, email@example.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/70f13d98-3811-4537-b430-2db91febb048
A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6b287f10-f93d-40f9-8c7f-05315fe4ccf2To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Moleac’s NeuroAiD™II Improves Post-Concussion Symptoms, Quality of Life, and Mood after a Mild Traumatic Brain Injury5.12.2023 04:41:56 CET | Press release
With its targeted multimodal approach, NeuroAiD™II offers a broad range of therapeutic benefits to TBI patients.NeuroAiD™II was well-tolerated by TBI patients with a favourable safety profile. SINGAPORE, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Moleac announced promising results from the SAMURAI double-blind study in patients with mild traumatic brain injury (mTBI) receiving a 6-month course of NeuroAiD™II. In the study, the NeuroAiD™II group showed significant improvement in their post-concussion symptoms, quality of life and mood, compared to those in the placebo group. Presented by Professor Valery Feigin at the World Congress of Neurology, last October in Montreal, these results expand the list of therapeutic benefits of NeuroAiD™II observed in previous clinical trials conducted on TBI patients, and confirm its favourable safety profile1, 2, 3. In the SAMURAI study, mTBI patients underwent a series of tests assessing various types of impairments and their recovery over time. For cognition
Nokia comments on AT&T vendor plans5.12.2023 03:30:00 CET | Press release
Nokia Corporation Stock Exchange Release 5 December 2023 at 4:30 EET Nokia comments on AT&T vendor plans Espoo, Finland – Nokia has a wide-ranging relationship with AT&T, supplying products and services across wireless, wireline and other network technologies, alongside similar relationships with other major North American network operators. Nokia is aware of AT&T’s plans to commit to an Open RAN deployment in collaboration with other vendors over the next five years. As a result, Nokia now expects revenue from AT&T in Mobile Networks will decrease over the next 2-3 years. AT&T accounted for 5-8% of Mobile Networks net sales year-to-date in 2023. The already announced action Nokia is taking to reduce its cost base is expected to partially mitigate the impact of AT&T’s decision. Nokia expects Mobile Networks to remain profitable over the coming years but this decision would delay the timeline of achieving double digit operating margin by up to 2 years. Nokia has invested heavily in the
Canadian Government Awards New Funding to General Fusion5.12.2023 02:00:00 CET | Press release
RICHMOND, Canada, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Today, General Fusion announced that Canada’s Strategic Innovation Fund (SIF) has awarded CA$5 million to support research and development to advance the company’s Magnetized Target Fusion (MTF) demonstration at its Richmond headquarters. Called LM26, this ground-breaking machine will progress major technical milestones required to commercialize zero-carbon fusion power by the early to mid-2030s. The funds are an addition to the existing contribution agreement with SIF, to support the development of General Fusion’s transformational technology. Fusion energy is the ultimate clean energy solution. It is what powers the sun and stars. It’s the process by which two light nuclei merge to form a heavier one, emitting a massive amount of energy. By 2100, the production and export of the Canadian industry’s fusion energy technology could provide up to $1.26 trillion in economic benefits to Canada. Additionally, fusion could completely offset
LeddarTech and Prospector Capital Corp. Announce Effectiveness of Registration Statement and December 13, 2023 Extraordinary General Meeting to Approve Business Combination4.12.2023 23:30:00 CET | Press release
QUEBEC CITY, Dec. 04, 2023 (GLOBE NEWSWIRE) -- LeddarTech Inc.® (“LeddarTech” or the “Company”), an automotive software company that provides patented disruptive AI-based low-level sensor fusion and perception software technology for ADAS and AD, and Prospector Capital Corp. (“Prospector”) (NASDAQ: PRSR, PRSRU, PRSRW), a publicly traded special-purpose acquisition company led by former Qualcomm President Derek Aberle and chaired by former Qualcomm Vice Chairman Steve Altman, today announced that on December 4, 2023 the U.S. Securities and Exchange Commission (the “SEC”) declared effective the Registration Statement on Form F-4, as amended, filed by LeddarTech Holdings Inc. (“Newco”) in connection with the previously announced proposed business combination (the “Business Combination”). The filing can be viewed in its entirety on the SEC’s website at www.sec.gov. Prospector also commenced mailing the definitive proxy statement/prospectus on December 4, 2023, which was included in the Reg
Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 20234.12.2023 22:30:00 CET | Press release
Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights11/30/2023 96,431,770 Total gross of voting rights: 96,431,770 Total net* of voting rights: 96,186,256 * Net total = total number of voting rights attached to shares – shares without voting rights Attachment PDF Version